What's behind the FDA's controversial strategy for evaluating new COVID boosters

https://www.npr.org/sections/health-shots/2022/08/18/1117778748/whats-behind-the-fdas-controversial-strategy-for-evaluating-new-covid-boosters

by whitepoplar • 4 years ago

7 5 4 years ago

npr.org

RichardCNormos2• 4 years ago

The billions of people who have gotten Moderna and Pfizer-BioNTech mRNA vaccines show how safe they are, those experts say.

I don't like that "testing in production" is now a norm in healthcare.

NoahKAndrews• 4 years ago

There were trials before they started giving them to the public.

_-david-_• 4 years ago

They never finished all the phases of the trials.

edmundsauto• 4 years ago

It looks more like "an acceptable tradeoff in emergent crises" than a norm. It's possible that it becomes more common, but this might mean shorter time to market for some products. It's possible we had overindexed on caution and this is a reasonable correction.

RichardCNormos2• 4 years ago

It will absolutely become more common. Launching a PR campaign to convince the public that a given disease is an "emergency" can save billions by side-stepping expensive clinical trials.

With the relatively low deadliness-to-panic ratio of COVID, the pharma industry now knows that this is possible.

What's behind the FDA's controversial strategy for evaluating new COVID boosters

Related Stories